These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 210061)

  • 1. LH-RH binding to purified pituitary plasma membranes: absence of adenylate cyclase activation.
    Clayton RN; Shakespear RA; Marshall JC
    Mol Cell Endocrinol; 1978 Jun; 11(1):63-78. PubMed ID: 210061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of gonadotropin-releasing hormone (LH-RH) to the pituitary plasma membranes and the problem of adenylate cyclase stimulation.
    Théoleyre M; Bérault A; Garnier J; Jutisz M
    Mol Cell Endocrinol; 1976 Oct; 5(5):365-77. PubMed ID: 824166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary.
    Collado B; Carmena MJ; Cortés J; Schally AV; Prieto JC
    Int J Oncol; 2004 Mar; 24(3):725-30. PubMed ID: 14767559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of luteinizing hormone-releasing hormone agonist and calcium upon adenylyl cyclase activity of human corpus luteum membranes.
    Rojas FJ; Asch RH
    Life Sci; 1985 Mar; 36(9):841-50. PubMed ID: 2983174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LH-RH interactions with pituitary receptors: Properties and characterization.
    Spona J
    Endocrinol Exp; 1975 Jun; 9(2):127-34. PubMed ID: 236171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further study on the effects of LH-RH in rat anterior pituitary.
    Yoshida T; Hattori Y; Hoshiai H; Suzuki M
    Tohoku J Exp Med; 1976 Sep; 120(1):71-4. PubMed ID: 183311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition of various LH--RH analogs and fragments with 135I-LH--RH for specific binding sites on isolated pituitary plasma membranes.
    Kuhl H; Baumann R; Sandow J; Taubert HD
    Mol Cell Endocrinol; 1980 Jan; 17(1):61-70. PubMed ID: 6244206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LH-RH interaction with the pituitary plasma membrane is affected by sex steroids.
    Spona J
    FEBS Lett; 1974 Feb; 39(2):221-4. PubMed ID: 4368885
    [No Abstract]   [Full Text] [Related]  

  • 10. LH-RH-sensitive adenylate cyclase in isolated plasma membranes of rat adenohypophyses.
    Spona J
    Endocrinol Exp; 1975 Jan; 9(1):27-34. PubMed ID: 179783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin binding to and adenylate cyclase activity of porcine thyroid plasma membranes.
    Verrier B; Planells R; Lissitzky S
    Eur J Biochem; 1977 Apr; 74(2):243-52. PubMed ID: 192550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
    Vandermeers A; Vandenborre S; Hou X; de Neef P; Robberecht P; Vandermeers-Piret MC; Christophe J
    Eur J Biochem; 1992 Sep; 208(3):815-9. PubMed ID: 1327769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation and analysis of two plasma membrane fractions from bovine thyroid which differ in TSH binding and TSH activation of adenylate cyclase.
    Champier J; Munari-Silem Y; Alquier C; Audebet C; Rousset B
    Mol Cell Endocrinol; 1985 Nov; 43(1):83-93. PubMed ID: 2998909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of adenylate cyclase activity and progesterone synthesis in ovine corpora lutea stimulated by different chemical derivatives or natural analogs of ovine LH.
    Jammes H; de la Llosa-Hermier MP; de la Llosa P; Hermier C
    Mol Cell Endocrinol; 1986 Sep; 47(1-2):107-17. PubMed ID: 3743887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase.
    Holmes MC; Antoni FA; Szentendrei T
    Neuroendocrinology; 1984 Aug; 39(2):162-9. PubMed ID: 6089019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LHRH-pituitary plasma membrane binding: the presence of specific binding sites in other tissues.
    Marshall JC; Shakespear RA; Odell WD
    Clin Endocrinol (Oxf); 1976 Nov; 5(6):671-7. PubMed ID: 188571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi.
    Gordeladze JO; Björo T; Torjesen PA; Ostberg BC; Haug E; Gautvik KM
    Eur J Biochem; 1989 Aug; 183(2):397-406. PubMed ID: 2569396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the epinephrine-mediated activation of adenylate cyclase in plasma membranes from liver and ascites hepatomas of rats.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1976 Dec; 455(2):297-314. PubMed ID: 187240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine adrenal cortex adenylate cyclase: properties of the particulate enzyme and effects of guanyl nucleotides.
    Glossmann H; Gips H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(1):77-97. PubMed ID: 171590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.